CONCORDBIO.BOCONCORDBIO.BOBSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank60
3Y CAGR+3.1%
5Y CAGR+0.4%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+3.1%/yr
Annual compound
5Y CAGR
+0.4%/yr
Consistent
Percentile
P60
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
202542.72%-0.9%
202443.13%+4.3%
202341.33%+6.1%
202238.97%-26.9%
202153.28%+27.5%
202041.78%-